Compounds > bucladesine

bucladesine and Shock, Septic

bucladesine has been researched along with Shock, Septic in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19904 (57.14)18.7374
1990's3 (42.86)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Catalano, RD; Parameswaran, V; Ramachandran, J; Trunkey, DD1
Finkelman, F; Fong, M; Kambayashi, T; Patil-Koota, V; Strassmann, G1
Ogawa, R; Okano, S; Tagawa, M; Urakawa, N1
Enzan, K; Horiguchi, T; Mitsuhata, H; Yanase, T1
Endo, T; Fujii, M; Nozaki, H; Okuaki, A; Sakamoto, Y; Suzuki, M1
Araki, E; Endo, T; Kou, SZ; Okuaki, A; Saito, K; Siow, C; Suzuki, M1
Ichikawa, T1

Other Studies

7 other study(ies) available for bucladesine and Shock, Septic

ArticleYear
Mechanisms of adrenocortical depression during Escherichia coli shock.
    Archives of surgery (Chicago, Ill. : 1960), 1984, Volume: 119, Issue:2

    Topics: Adrenal Cortex; Adrenocorticotropic Hormone; Animals; Bucladesine; Cells, Cultured; Corticosterone; Cyclic AMP; Escherichia coli Infections; Hydrocortisone; Male; Models, Biological; Rabbits; Rats; Shock, Septic

1984
Evidence for the involvement of interleukin 10 in the differential deactivation of murine peritoneal macrophages by prostaglandin E2.
    The Journal of experimental medicine, 1994, Dec-01, Volume: 180, Issue:6

    Topics: 1-Methyl-3-isobutylxanthine; Analysis of Variance; Animals; Antibodies, Monoclonal; Biological Assay; Bucladesine; Cells, Cultured; Crosses, Genetic; Cyclic AMP; Cyclic GMP; Enzyme-Linked Immunosorbent Assay; Interleukin-10; Interleukin-6; Kinetics; Lactates; Lipopolysaccharides; Macrophage Activation; Macrophages, Peritoneal; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Nitric Oxide; Prostaglandins E; Shock, Septic; Tumor Necrosis Factor-alpha

1994
Effect of dibutyryl cyclic AMP on hemodynamics and chemical mediators in dogs with experimentally-induced endotoxic shock.
    The Journal of veterinary medical science, 1993, Volume: 55, Issue:6

    Topics: 6-Ketoprostaglandin F1 alpha; Animals; Blood Pressure; Bucladesine; Cardiac Output; Dogs; Endotoxins; Escherichia coli; Heart Rate; Hemodynamics; Injections, Intravenous; Shock, Septic; Thromboxane B2; Time Factors; Urine; Vascular Resistance

1993
Dibutyryl cAMP improves systemic vasoconstriction caused by endotoxin in dogs.
    Shock (Augusta, Ga.), 1996, Volume: 5, Issue:4

    Topics: Animals; Blood Pressure; Bucladesine; Cardiac Output; Cyclic AMP; Dogs; Dose-Response Relationship, Drug; Escherichia coli Infections; Hemodynamics; Lethal Dose 50; Lipopolysaccharides; Shock, Septic; Thromboxane B2; Time Factors; Vascular Resistance; Vasoconstriction

1996
[Studies on distribution of cardiac output. --2. Effects of dibutyryl cyclic-AMP on cardiac output, organ blood flow and blood flow distribution ratio in endotoxin shock (author's transl)].
    Masui. The Japanese journal of anesthesiology, 1978, Volume: 27, Issue:7

    Topics: Animals; Blood Circulation; Bucladesine; Cardiac Output; Dogs; Hemodynamics; Renal Artery; Shock, Septic

1978
[Effects of various drugs on microaggregate formation in endotoxin shock (author's transl)].
    Masui. The Japanese journal of anesthesiology, 1979, Volume: 28, Issue:12

    Topics: Animals; Aspirin; Bucladesine; Dogs; Methylprednisolone; Platelet Aggregation; Platelet Count; Shock, Septic

1979
[Effects of coenzyme Q and dibutyryl cAMP on endocrine and renal functions in endotoxin shock (author's transl)].
    Masui. The Japanese journal of anesthesiology, 1979, Volume: 28, Issue:8

    Topics: Aldosterone; Animals; Bucladesine; Dogs; Hormones; Kidney; Renin; Shock, Septic; Ubiquinone; Vasopressins

1979